Literature DB >> 20473520

Pneumococcal vaccination: time to move on?

Marijke Johanna Proesmans.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20473520     DOI： 10.1007/s00431-010-1215-6

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  23 in total

Review 1.  Clinical evaluation of new pneumococcal vaccines: the Finnish approach.

Authors:  J Eskola; A K Takala; T M Kilpi; K S Lankinen; H Käyhty
Journal:  Dev Biol Stand       Date:  1998

Review 2.  Epidemiology and prevention of pneumococcal infections.

Authors:  P McIntyre
Journal:  Curr Opin Pediatr       Date:  1997-02       Impact factor: 2.856

3.  Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.

Authors:  Rekha Pai; Matthew R Moore; Tamara Pilishvili; Robert E Gertz; Cynthia G Whitney; Bernard Beall
Journal:  J Infect Dis       Date:  2005-11-01       Impact factor: 5.226

4.  Pneumococcal vaccine.

Authors:  P J Torzillo
Journal:  Aust Fam Physician       Date:  1997-08

5.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

6.  Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage.

Authors:  Rosalyn J Singleton; Thomas W Hennessy; Lisa R Bulkow; Laura L Hammitt; Tammy Zulz; Debby A Hurlburt; Jay C Butler; Karen Rudolph; Alan Parkinson
Journal:  JAMA       Date:  2007-04-25       Impact factor: 56.272

7.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

8.  Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

Authors:  Sheldon L Kaplan; Edward O Mason; Ellen R Wald; Gordon E Schutze; John S Bradley; Tina Q Tan; Jill A Hoffman; Laurence B Givner; Ram Yogev; William J Barson
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

9.  Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Authors:  Allison F Messina; Kathy Katz-Gaynor; Theresa Barton; Naveed Ahmad; Faryal Ghaffar; David Rasko; George H McCracken
Journal:  Pediatr Infect Dis J       Date:  2007-06       Impact factor: 2.129

10.  Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience.

Authors:  Pierre Alex Crisinel; Isabelle Chevalier; Fabien Rallu; Bruce Tapiero; Valérie Lamarre; Roseline Thibault; Philippe Ovetchkine
Journal:  Eur J Pediatr       Date:  2010-05-22       Impact factor: 3.183
View more
  1 in total

1.  An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease.

Authors:  Nigel W Crawford; Anthony G Catto-Smith; Mark R Oliver; Donald J S Cameron; Jim P Buttery
Journal:  BMC Gastroenterol       Date:  2011-07-29       Impact factor: 3.067
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.